Der er omfattende klinisk dokumentation for, at interaktion mellem clopidogrel og cerivastatin medfører øgede plasmaniveauer af cerivastatin og en deraf følgende øget risiko for rabdomyolyse.
There is a large amount of clinical evidence for an interaction between clopidogrel and cerivastatin leading to increased plasma levels of cerivastatin and hence an increased risk of rhabdomyolysis.